DiscoverStroke FM22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke
22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke

22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke

Update: 2021-09-27
Share

Description

This is an official Canadian Stroke Consortium (CSC) - StrokeFM Podcast episode:

Neuroprotection and stroke care

What does the future hold?  Where are we coming from and where are we going?  These and other exciting topics of discussion in conversation with Dr. Michael Hill (Calgary Stroke Program) as we chat about ESCAPE NA1 and ESCAPE NEXT. ESCAPE-NEXT is a multi-centre, randomized, double-blinded, placebo-controlled, parallel Group, single-dose trial designed to determine the efficacy and safety of Nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis. This is an official CSC Podcast episode (Season 2, Episode 8). As usual, see our Disclaimer about this educational podcast. 


Please follow us on Twitter: @strokefm

Subscribe to the Podcast and give us 5 stars!

Apple PodCast

Spotify PodCast

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke

22 CSC Stroke FM - To Serve and Protect: Neuroprotection in Stroke

Stroke FM